Singapore
National Centre for Infectious Diseases
COVID-19, SARS-CoV-2, Delta, Omicron, variants of concern, vaccine breakthrough
COVID-19, SARS-CoV-2, early-treatment, sotrovimab, remdesivir, high-risk